-
1
-
-
34548570424
-
-
National Cancer Registry. Department of Health, Dublin, Ireland.
-
National Cancer Registry. Cancer in Ireland, 1994-1998. Department of Health, Dublin, Ireland. 2004
-
(2004)
Cancer in Ireland, 1994-1998
-
-
-
2
-
-
0036010518
-
Selective p38 activation in human non-small cell lung cancer
-
Greenberg AK, Basu S, Hu J, et al. Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol 2002;26:558-64
-
(2002)
Am J Respir Cell Mol Biol
, vol.26
, pp. 558-64
-
-
Greenberg, A.K.1
Basu, S.2
Hu, J.3
-
3
-
-
0036839830
-
The role of COX-2 inhibitors in lung cancer
-
Qadri SSA, Wang JH, Redmond KC, O'Donnell AF, Aherne T, Redmond HP. The role of COX-2 inhibitors in lung cancer. Ann Thorac Surg 2002;74:1648-52
-
(2002)
Ann Thorac Surg
, vol.74
, pp. 1648-52
-
-
Qadri, S.S.A.1
Wang, J.H.2
Redmond, K.C.3
O'Donnell, A.F.4
Aherne, T.5
Redmond, H.P.6
-
4
-
-
14244255483
-
Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition
-
Qadri SSA, Wang JH, Coffey JC, et al. Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. Ann Thorac Surg 2005;79:990-5
-
(2005)
Ann Thorac Surg
, vol.79
, pp. 990-5
-
-
Qadri, S.S.A.1
Wang, J.H.2
Coffey, J.C.3
-
5
-
-
3042748128
-
The role of COX-2 inhibition in breast cancer treatment and prevention
-
2 Suppl 7
-
Arun B, Goss P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol 2004;31(2 Suppl 7):22-9
-
(2004)
Semin Oncol
, vol.31
, pp. 22-9
-
-
Arun, B.1
Goss, P.2
-
6
-
-
22344439728
-
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (review)
-
Harris RE, Beebe-Donk J, Doss H, Burr-Doss D. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 2005;13:559-83
-
(2005)
Oncol Rep
, vol.13
, pp. 559-83
-
-
Harris, R.E.1
Beebe-Donk, J.2
Doss, H.3
Burr-Doss, D.4
-
8
-
-
6344280568
-
Aspirin use and mortality from cancer in a prospective cohort study
-
5B
-
Ratnasinghe LD, Graubard BI, Kahle L, et al. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 2004;24(5B):3177-84
-
(2004)
Anticancer Res
, vol.24
, pp. 3177-84
-
-
Ratnasinghe, L.D.1
Graubard, B.I.2
Kahle, L.3
-
9
-
-
33644837942
-
Non-steroidal anti-inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics
-
Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006;6:130-40
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 130-40
-
-
Ulrich, C.M.1
Bigler, J.2
Potter, J.D.3
-
10
-
-
29244449354
-
Prostaglandins and cancer
-
Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006;55:115-22
-
(2006)
Gut
, vol.55
, pp. 115-22
-
-
Wang, D.1
Dubois, R.N.2
-
11
-
-
33744479992
-
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer
-
Dai Y, Wang WH. Non-steroidal anti-inflammatory drugs in prevention of gastric cancer. World J Gastroenterol 2006;12:2884-9
-
(2006)
World J Gastroenterol
, vol.12
, pp. 2884-9
-
-
Dai, Y.1
Wang, W.H.2
-
12
-
-
33744997893
-
Cyclooxygenase-2 as a signaling molecule in radiation-induced bystander effect
-
Hei TK. Cyclooxygenase-2 as a signaling molecule in radiation-induced bystander effect. Mol Carcinog 2006;45:455-60
-
(2006)
Mol Carcinog
, vol.45
, pp. 455-60
-
-
Hei, T.K.1
-
14
-
-
33646697113
-
Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors (review)
-
Onguru O, Casey MB, Kajita S, et al. Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors (review). Endocr Pathol 2005;16:253-77
-
(2005)
Endocr Pathol
, vol.16
, pp. 253-77
-
-
Onguru, O.1
Casey, M.B.2
Kajita, S.3
-
15
-
-
33744484033
-
Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: Topical therapeutic strategies targeting COX-2 expression and activity
-
Telliez A, Furman C, Pommery N, Henichart JP. Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity. Anticancer Agents Med Chem 2006;6:187-208
-
(2006)
Anticancer Agents Med Chem
, vol.6
, pp. 187-208
-
-
Telliez, A.1
Furman, C.2
Pommery, N.3
Henichart, J.P.4
-
16
-
-
0030606299
-
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
-
Oshima M, Dinchuk JE, Kargman S, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9
-
(1996)
Cell
, vol.87
, pp. 803-9
-
-
Oshima, M.1
Dinchuk, J.E.2
Kargman, S.3
-
17
-
-
0035866401
-
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor
-
Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001;61:1733-40
-
(2001)
Cancer Res
, vol.61
, pp. 1733-40
-
-
Oshima, M.1
Murai, N.2
Kargman, S.3
-
18
-
-
0033735989
-
Increased cyclooxygenase-2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung
-
Hosomi Y, Yokose T, Hirose Y, et al. Increased cyclooxygenase-2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 2000;30:73-81
-
(2000)
Lung Cancer
, vol.30
, pp. 73-81
-
-
Hosomi, Y.1
Yokose, T.2
Hirose, Y.3
-
19
-
-
0032533858
-
Expression of cyclooxygenase-2 in human lung carcinoma
-
Wolff H, Saukkonen K, Anttila A, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1999;58:4997-5001
-
(1999)
Cancer Res
, vol.58
, pp. 4997-5001
-
-
Wolff, H.1
Saukkonen, K.2
Anttila, A.3
Karjalainen, A.4
Vainio, H.5
Ristimaki, A.6
-
20
-
-
0034901568
-
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
-
Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 2001;7:861-7
-
(2001)
Clin Cancer Res
, vol.7
, pp. 861-7
-
-
Khuri, F.R.1
Wu, H.2
Lee, J.J.3
-
21
-
-
34548550780
-
PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells
-
Ikezoe T, Yang Y, Saitoh T, et al. PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells. Int J Oncol 2006;29:453-61
-
(2006)
Int J Oncol
, vol.29
, pp. 453-61
-
-
Ikezoe, T.1
Yang, Y.2
Saitoh, T.3
-
22
-
-
33745929929
-
Has Cox-2 a prognostic role in non-small-cell lung cancer? a systematic review of the literature with meta-analysis of the survival results
-
Mascaux C, Martin B, Paesmans M, et al. Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results. Br J Cancer 2006;95:139-45
-
(2006)
Br J Cancer
, vol.95
, pp. 139-45
-
-
Mascaux, C.1
Martin, B.2
Paesmans, M.3
-
23
-
-
0038662905
-
Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells
-
Nakata H, Uemura Y, Kobayashi M, Harada R, Taguchi H. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Cancer Sci 2003;94:173-80
-
(2003)
Cancer Sci
, vol.94
, pp. 173-80
-
-
Nakata, H.1
Uemura, Y.2
Kobayashi, M.3
Harada, R.4
Taguchi, H.5
-
24
-
-
15944388899
-
Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer
-
Tseng WW, Deganutti A, Chen MN, Saxton RE, Liu CD. Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer. J Gastrointest Surg 2002;6:838-44
-
(2002)
J Gastrointest Surg
, vol.6
, pp. 838-44
-
-
Tseng, W.W.1
Deganutti, A.2
Chen, M.N.3
Saxton, R.E.4
Liu, C.D.5
-
25
-
-
0037311125
-
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice
-
Yao M, Kargman S, Lam CE, et al. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res 2003;63:586-92
-
(2003)
Cancer Res
, vol.63
, pp. 586-92
-
-
Yao, M.1
Kargman, S.2
Lam, C.E.3
-
26
-
-
29144501209
-
Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation
-
Chang YJ, Wu MS, Lin JT, Chen CC. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005;175:8242-52
-
(2005)
J Immunol
, vol.175
, pp. 8242-52
-
-
Chang, Y.J.1
Wu, M.S.2
Lin, J.T.3
Chen, C.C.4
-
27
-
-
33644599163
-
Current directions for COX-2 inhibition in breast cancer
-
Suppl 2
-
Chow LW, Loo WT, Toi M. Current directions for COX-2 inhibition in breast cancer. Biomed Pharmacother 2005;59(Suppl 2):S281-4
-
(2005)
Biomed Pharmacother
, vol.59
, pp. 281-4
-
-
Chow, L.W.1
Loo, W.T.2
Toi, M.3
-
28
-
-
32044443138
-
The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice
-
Klenke FM, Gebhard MM, Ewerbeck V, et al. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. BMC Cancer 2006;6:9
-
(2006)
BMC Cancer
, vol.6
, pp. 9
-
-
Klenke, F.M.1
Gebhard, M.M.2
Ewerbeck, V.3
-
29
-
-
33644527957
-
Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts
-
Suppl 2
-
Wu YL, Fu SL, Zhang YP, et al. Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts. Biomed Pharmacother 2005;59(Suppl 2):S289-92
-
(2005)
Biomed Pharmacother
, vol.59
, pp. 289-92
-
-
Wu, Y.L.1
Fu, S.L.2
Zhang, Y.P.3
-
30
-
-
33644874276
-
Anti-angiogenic effects of hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma
-
Yee KK, Soo KC, Olivo M. Anti-angiogenic effects of hypericin- photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. Int J Mol Med 2005;16:993-1002
-
(2005)
Int J Mol Med
, vol.16
, pp. 993-1002
-
-
Yee, K.K.1
Soo, K.C.2
Olivo, M.3
-
31
-
-
0242486770
-
Rofecoxib reduces polyp recurrence in familial polyposis
-
Hallak A, Alon-Baron L, Shamir R, et al. Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci 2003;48:1998-2002
-
(2003)
Dig Dis Sci
, vol.48
, pp. 1998-2002
-
-
Hallak, A.1
Alon-Baron, L.2
Shamir, R.3
-
33
-
-
0037960862
-
Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive
-
Lew JI, Guo Y, Kim RK, et al. Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive. J Gastrointest Surg 2002;6:563-8
-
(2002)
J Gastrointest Surg
, vol.6
, pp. 563-8
-
-
Lew, J.I.1
Guo, Y.2
Kim, R.K.3
-
34
-
-
33646922353
-
Celecoxib shown effective in preventing colon polyps
-
Nelson NJ. Celecoxib shown effective in preventing colon polyps. J Natl Cancer Inst 2006;98:665-7
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 665-7
-
-
Nelson, N.J.1
-
35
-
-
0037183979
-
Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression
-
Wang JH, Doyle M, Manning BJ, et al. Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J Biol Chem 2002;277:36068-75
-
(2002)
J Biol Chem
, vol.277
, pp. 36068-75
-
-
Wang, J.H.1
Doyle, M.2
Manning, B.J.3
-
36
-
-
31844432409
-
The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy
-
Coffey JC, Wang JH, Bouchier-Hayes D, et al. The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy. Ann Surg 2006;243:250-6
-
(2006)
Ann Surg
, vol.243
, pp. 250-6
-
-
Coffey, J.C.1
Wang, J.H.2
Bouchier-Hayes, D.3
-
37
-
-
20444380697
-
Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy
-
Coffey JC, Wang JH, Smith MJ, et al. Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy. J Biol Chem 2005;280:20968-77
-
(2005)
J Biol Chem
, vol.280
, pp. 20968-77
-
-
Coffey, J.C.1
Wang, J.H.2
Smith, M.J.3
-
38
-
-
0036468287
-
Cyclooxygenase inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo
-
Leahy KM, Ornberg RL, Wang Y, et al. Cyclooxygenase inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002;62:625-31
-
(2002)
Cancer Res
, vol.62
, pp. 625-31
-
-
Leahy, K.M.1
Ornberg, R.L.2
Wang, Y.3
-
39
-
-
0034026144
-
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines
-
Hida T, Kozaki KI, Muramatsu H, et al. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 2000;6:2006-11
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2006-11
-
-
Hida, T.1
Kozaki, K.I.2
Muramatsu, H.3
-
40
-
-
23944482453
-
Can surgery for cancer accelerate the progression of secondary tumors within residual minimal disease at both local and systemic levels?
-
Qadri SS, Wang JH, Coffey JC, et al. Can surgery for cancer accelerate the progression of secondary tumors within residual minimal disease at both local and systemic levels? Ann Thorac Surg 2005;80:1046-50
-
(2005)
Ann Thorac Surg
, vol.80
, pp. 1046-50
-
-
Qadri, S.S.1
Wang, J.H.2
Coffey, J.C.3
-
41
-
-
0003504049
-
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
-
Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, Dubois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16
-
(1998)
Cell
, vol.93
, pp. 705-16
-
-
Tsuji, M.1
Kawano, S.2
Tsuji, S.3
Sawaoka, H.4
Hori, M.5
Dubois, R.N.6
|